IBS - IRRITABLE BOWEL SYNDROME
Clinical trials for IBS - IRRITABLE BOWEL SYNDROME explained in plain language.
Never miss a new study
Get alerted when new IBS - IRRITABLE BOWEL SYNDROME trials appear
Sign up with your email to follow new studies for IBS - IRRITABLE BOWEL SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a Mucus-Busting supplement boost an IBS drug?
Symptom relief Recruiting nowThis study tests whether adding a dietary supplement called NAC to the standard IBS-D drug rifaximin can better relieve stomach pain and diarrhea. About 225 adults with IBS-D will receive either the combination or a placebo. The goal is to see if NAC helps break down mucus in the…
Matched conditions: IBS - IRRITABLE BOWEL SYNDROME
Phase: PHASE2 • Sponsor: Mark Pimentel, MD • Aim: Symptom relief
Last updated Jun 22, 2026 12:09 UTC
-
Brain zaps calm IBS pain: new hope for gut sufferers
Symptom relief Recruiting nowThis study tests whether low-frequency magnetic pulses aimed at a specific brain region can reduce chronic abdominal pain in people with irritable bowel syndrome with diarrhea (IBS-D). 42 adults with IBS-D will receive either real or sham stimulation over two weeks, with neither …
Matched conditions: IBS - IRRITABLE BOWEL SYNDROME
Phase: NA • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Symptom relief
Last updated Jun 22, 2026 12:05 UTC
-
Could a common probiotic soothe IBS? new trial seeks answers
Symptom relief Recruiting nowThis study tests whether a probiotic called Saccharomyces boulardii can reduce symptoms of irritable bowel syndrome (IBS) in adults. About 406 people with non-constipated IBS will take either the probiotic or a placebo daily for 8 weeks. Researchers will measure changes in sympto…
Matched conditions: IBS - IRRITABLE BOWEL SYNDROME
Phase: PHASE3 • Sponsor: Biocodex • Aim: Symptom relief
Last updated Jun 17, 2026 12:05 UTC
-
New combo therapy aims to calm IBS diarrhea
Symptom relief Recruiting nowThis early study at Mayo Clinic tests whether adding a medication called mirtazapine to a low-FODMAP diet works better than diet alone for easing IBS with diarrhea. About 20 adults aged 18-70 will take part. The goal is to reduce belly pain, bloating, and improve stool consistenc…
Matched conditions: IBS - IRRITABLE BOWEL SYNDROME
Phase: EARLY_PHASE1 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 17, 2026 12:02 UTC
-
New gut health mix could soothe irritable bowel syndrome
Symptom relief Recruiting nowThis study tests whether a daily drink mix containing special sugars (HMO-2FL) and a postbiotic can reduce stomach pain, bloating, and other IBS symptoms. About 402 adults with IBS will take either the supplement or a placebo for 6 weeks. Researchers will compare symptom scores t…
Matched conditions: IBS - IRRITABLE BOWEL SYNDROME
Phase: NA • Sponsor: dsm-firmenich Switzerland AG • Aim: Symptom relief
Last updated Jun 12, 2026 12:04 UTC
-
New enzyme blend could be the key to beating bloating
Symptom relief Recruiting nowThis study tests whether a daily enzyme supplement (FODZYME®) can reduce bloating and stomach pain in adults who often feel bloated. About 150 people will take either the enzyme or a placebo for a period, then switch, to see if the enzyme helps break down hard-to-digest carbs. Th…
Matched conditions: IBS - IRRITABLE BOWEL SYNDROME
Phase: NA • Sponsor: Kiwi Health Inc • Aim: Symptom relief
Last updated Jun 11, 2026 12:10 UTC
-
New belt may tame tummy troubles for IBS sufferers
Symptom relief Recruiting nowThis study tests a non-invasive belt-like device (Variable Compression System) for people with moderate to severe Irritable Bowel Syndrome (IBS). Twenty participants will wear the device for at least 6 hours daily to see if it safely reduces IBS symptoms like pain, bloating, and …
Matched conditions: IBS - IRRITABLE BOWEL SYNDROME
Phase: NA • Sponsor: PGP Health • Aim: Symptom relief
Last updated Jun 08, 2026 13:07 UTC
-
New hope for IBS sufferers: allergy drug may beat standard treatment
Symptom relief Recruiting nowThis study tests whether ebastine, an allergy medication, works better than mebeverine, a common IBS drug, for reducing belly pain and improving daily life. About 200 adults with non-constipated IBS will take one of the two pills for 12 weeks. The goal is to see if ebastine provi…
Matched conditions: IBS - IRRITABLE BOWEL SYNDROME
Phase: PHASE3 • Sponsor: Guy Boeckxstaens • Aim: Symptom relief
Last updated Jun 02, 2026 11:40 UTC
-
Gut bacteria clues sought for Post-Infection IBS
Knowledge-focused Recruiting nowThis observational study is looking at the gut microbiome of 315 people, including those with irritable bowel syndrome that started after an infection. Researchers will compare their gut bacteria to people who had an infection but no IBS, and to healthy controls. The goal is to f…
Matched conditions: IBS - IRRITABLE BOWEL SYNDROME
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jun 23, 2026 12:09 UTC
-
Could celiac relatives have undiagnosed wheat sensitivity?
Knowledge-focused Recruiting nowThis study aims to find out how many relatives of people with celiac disease have non-celiac wheat sensitivity (NCWS) or irritable bowel syndrome (IBS) not caused by wheat. Researchers will ask 600 adult relatives to follow a wheat-free diet for 6 weeks and complete online questi…
Matched conditions: IBS - IRRITABLE BOWEL SYNDROME
Phase: NA • Sponsor: University of Palermo • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:55 UTC
-
IBS study: does weak starch digestion spike gut troubles?
Knowledge-focused Recruiting nowThis study looks at people with Irritable Bowel Syndrome (IBS) who have a reduced ability to break down starch and sugar due to low enzyme levels. Researchers want to see if these individuals have a smaller rise in blood sugar after a meal and more bowel symptoms compared to thos…
Matched conditions: IBS - IRRITABLE BOWEL SYNDROME
Phase: NA • Sponsor: Region Skane • Aim: Knowledge-focused
Last updated Jun 12, 2026 12:06 UTC